Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HL vs GSK✓SelectedUSD · GSKHL vs GSK performance historyLatest closeAs of-1.87%11/13
Stock and ETF performance explorer

HL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+249.6%
GSK return
+65.8%
Excess return
+183.8%
Maximum drawdown
-58.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%+0.5%-2.4%-2.0%
7D-11.1%+1.1%-12.3%-11.3%
30D-12.1%+6.3%-18.4%-12.8%
3M-26.1%+1.8%-27.9%-26.2%
6M-37.7%+1.7%-39.4%-38.0%
YTD-31.7%+6.5%-38.2%-32.4%
1Y-11.6%+9.5%-21.1%-13.0%
3Y+249.6%+65.3%+184.3%+179.7%
All+249.6%+65.8%+183.8%+179.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling